CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 40 enrolled
Drug / intervention
iFS Femtosecond Laser Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01348854
NCT01348854Phase 2Completed
CompareCT.gov

A Multi-Center Prospective Study to Evaluate the Safety and Effectiveness of Arcuate Incisions Performed With the IntraLase iFS Femtosecond Laser System

Abbott Medical Optics·interventional·Posted May 6, 2011·Updated Jun 4, 2014

In Brief

A Phase 2 clinical trial evaluating iFS Femtosecond Laser System for Corneal Astigmatism. Completed, enrolled 40 participants across 4 sites in 3 countries.

Detailed Summary

To determine if arcuate incisions performed with the iFS femtosecond laser are safe and effective in reducing corneal astigmatism.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCorneal Astigmatism
CountriesAustria, France, Germany
Collaborators--

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 6, 2011
Enrollment StartMay 1, 2011
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 15.2 years ago

Interventions

iFS Femtosecond Laser Systemdevice

arcuate incisions placed with the iFS femtosecond laser